Aeolus Pharmaceuticals (AOLS)

[jimbob4stocks]

BARDA's decision was heavily because of AOLS not having their sh*t together.

At the In-Process Review meeting on February 2, 2017, AMCG/BARDA provided the decision-making body with the wrong slides for the meeting. Aeolus was forced to present its case for option exercise with a presentation that did not contain critical, up-to-date information on the program's status and accomplishments.

Has nothing to do with AEOL 10150. They have teamed up for many years to develop the drug and I'm confident we get the approval for Lung-ARS treatment. Just my opinion though